BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38180081)

  • 1. Proteomic analysis shows decreased type I fibers and ectopic fat accumulation in skeletal muscle from women with PCOS.
    Stener-Victorin E; Eriksson G; Mohan Shrestha M; Rodriguez Paris V; Lu H; Banks J; Samad M; Perian C; Jude B; Engman V; Boi R; Nilsson E; Ling C; Nyström J; Wernstedt Asterholm I; Turner N; Lanner J; Benrick A
    Elife; 2024 Jan; 12():. PubMed ID: 38180081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen signaling in adipose tissue, but less likely skeletal muscle, mediates development of metabolic traits in a PCOS mouse model.
    Xiong T; Rodriguez Paris V; Edwards MC; Hu Y; Cochran BJ; Rye KA; Ledger WL; Padmanabhan V; Handelsman DJ; Gilchrist RB; Walters KA
    Am J Physiol Endocrinol Metab; 2022 Aug; 323(2):E145-E158. PubMed ID: 35658542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
    Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
    Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women With Polycystic Ovary Syndrome.
    O'Reilly MW; Kempegowda P; Walsh M; Taylor AE; Manolopoulos KN; Allwood JW; Semple RK; Hebenstreit D; Dunn WB; Tomlinson JW; Arlt W
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3327-3339. PubMed ID: 28645211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance.
    Ciaraldi TP; Aroda V; Mudaliar S; Chang RJ; Henry RR
    J Clin Endocrinol Metab; 2009 Jan; 94(1):157-63. PubMed ID: 18854391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional and Epigenetic Changes Influencing Skeletal Muscle Metabolism in Women With Polycystic Ovary Syndrome.
    Nilsson E; Benrick A; Kokosar M; Krook A; Lindgren E; Källman T; Martis MM; Højlund K; Ling C; Stener-Victorin E
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4465-4477. PubMed ID: 30113663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanisms in Skeletal Muscle Underlying Insulin Resistance in Women Who Are Lean With Polycystic Ovary Syndrome.
    Hansen SL; Svendsen PF; Jeppesen JF; Hoeg LD; Andersen NR; Kristensen JM; Nilas L; Lundsgaard AM; Wojtaszewski JFP; Madsbad S; Kiens B
    J Clin Endocrinol Metab; 2019 May; 104(5):1841-1854. PubMed ID: 30544235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated subcutaneous abdominal stem cell adipogenesis predicts insulin sensitivity in normal-weight women with polycystic ovary syndrome.
    Dumesic DA; Tulberg A; Leung KL; Fisch SC; Grogan TR; Abbott DH; Naik R; Chazenbalk GD
    Fertil Steril; 2021 Jul; 116(1):232-242. PubMed ID: 33341231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal Muscle Immunometabolism in Women With Polycystic Ovary Syndrome: A Meta-Analysis.
    Manti M; Stener-Victorin E; Benrick A
    Front Physiol; 2020; 11():573505. PubMed ID: 33192572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor β1 impairs the transcriptomic response to contraction in myotubes from women with polycystic ovary syndrome.
    McIlvenna LC; Altıntaş A; Patten RK; McAinch AJ; Rodgers RJ; Stepto NK; Barrès R; Moreno-Asso A
    J Physiol; 2022 Jul; 600(14):3313-3330. PubMed ID: 35760527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrical vs manual acupuncture stimulation in a rat model of polycystic ovary syndrome: different effects on muscle and fat tissue insulin signaling.
    Johansson J; Mannerås-Holm L; Shao R; Olsson A; Lönn M; Billig H; Stener-Victorin E
    PLoS One; 2013; 8(1):e54357. PubMed ID: 23349861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.
    de Medeiros SF; Rodgers RJ; Norman RJ
    Hum Reprod Update; 2021 Jun; 27(4):771-796. PubMed ID: 33764457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance.
    Jones H; Sprung VS; Pugh CJ; Daousi C; Irwin A; Aziz N; Adams VL; Thomas EL; Bell JD; Kemp GJ; Cuthbertson DJ
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3709-16. PubMed ID: 22837189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized clinical trial: effect of low-dose flutamide on abdominal adipogenic function in normal-weight women with polycystic ovary syndrome.
    Dumesic DA; Winnett C; Lu G; Grogan TR; Abbott DH; Naik R; Chazenbalk GD
    Fertil Steril; 2023 Jan; 119(1):116-126. PubMed ID: 36400597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
    Sanchez-Garrido MA; Tena-Sempere M
    Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of exercise training on insulin sensitivity, mitochondria and computed tomography muscle attenuation in overweight women with and without polycystic ovary syndrome.
    Hutchison SK; Teede HJ; Rachoń D; Harrison CL; Strauss BJ; Stepto NK
    Diabetologia; 2012 May; 55(5):1424-34. PubMed ID: 22246378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome.
    Tosi F; Dorizzi R; Castello R; Maffeis C; Spiazzi G; Zoppini G; Muggeo M; Moghetti P
    Eur J Endocrinol; 2009 Nov; 161(5):737-45. PubMed ID: 19713424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic changes in chromatin accessibility, altered adipogenic gene expression, and total versus de novo fatty acid synthesis in subcutaneous adipose stem cells of normal-weight polycystic ovary syndrome (PCOS) women during adipogenesis: evidence of cellular programming.
    Leung KL; Sanchita S; Pham CT; Davis BA; Okhovat M; Ding X; Dumesic P; Grogan TR; Williams KJ; Morselli M; Ma F; Carbone L; Li X; Pellegrini M; Dumesic DA; Chazenbalk GD
    Clin Epigenetics; 2020 Nov; 12(1):181. PubMed ID: 33228780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome.
    Corbould A; Dunaif A
    Metabolism; 2007 May; 56(5):716-22. PubMed ID: 17445549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.